OneSource Specialty Pharma files FY26 BRSR report with zero liquid discharge

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights
  • OneSource Specialty Pharma filed its FY26 BRSR report disclosing ₹14,204 million standalone turnover
  • Renewable energy consumption rose to 1,13,219 GJ while non-renewable fuel use dropped significantly
  • Company achieved zero liquid discharge with no external water release from manufacturing units
  • Permanent employee turnover declined to 23% from 27% in the prior fiscal year
  • SGS India provided reasonable assurance on core sustainability indicators
powered bylight_fuzz_icon
49742776

*this image is generated using AI for illustrative purposes only.

OneSource Specialty Pharma has submitted its Business Responsibility & Sustainability Report (BRSR) for the financial year ended March 31, 2026. The filing, dated August 31, 2026, discloses key sustainability metrics including energy consumption, water management, and waste handling across its operations.

The company reported a standalone turnover of ₹14,204 million and a net worth of ₹59,430.95 million. Its workforce comprises 1,200 permanent employees and 1,089 workers. Exports accounted for 70.80% of total turnover, serving customers in over 30 countries.

Environmental Metrics

OneSource Specialty Pharma highlighted significant strides in resource efficiency and emission control during FY26.

Metric FY26 FY25
Total Energy Consumed (GJ) 1,40,062.83 1,55,680
Renewable Energy Share (%) 80.83% 71.00%
Total Water Withdrawal (KL) 2,55,733.71 2,12,667.1
Scope 1 + 2 GHG Emissions (MT CO2e) 14,836.46 12,672.7

The entity achieved zero liquid discharge across all manufacturing units, with no water discharged outside premises. Renewable energy consumption rose to 1,13,219.09 GJ, up from 1,10,514 GJ in the prior year. Conversely, non-renewable fuel consumption dropped sharply to 2,802.30 GJ from 20,279 GJ in FY25.

Waste and Circular Economy

Total waste generated increased to 838.114 metric tonnes from 738 metric tonnes in FY25. However, recycling efforts intensified, with 541.69 metric tonnes recovered through recycling, compared to 481.64 metric tonnes previously. Hazardous waste constituted a significant portion, with other hazardous waste rising to 269.695 metric tonnes.

Social and Governance Highlights

The company reported a permanent employee turnover rate of 23% in FY26, down from 27% in FY25. Women constitute 15% of permanent employees and 13% of the Board of Directors. No safety-related incidents, including lost-time injuries or fatalities, were recorded for employees or workers.

SGS India Private Limited provided reasonable assurance on the core indicators of the BRSR report, confirming data accuracy and compliance with SEBI regulations.

Historical Stock Returns for Onesource Specialty Pharma

1 Day5 Days1 Month6 Months1 Year5 Years
-0.85%-1.04%-12.26%+12.79%-18.11%0.0%

How might the increase in Scope 1 and 2 GHG emissions despite higher renewable energy adoption impact OneSource's carbon credit liabilities or ESG ratings in FY27?

What strategic initiatives is OneSource planning to implement to reverse the upward trend in total water withdrawal and hazardous waste generation?

Could the 23% employee turnover rate pose risks to operational continuity or institutional knowledge retention in the specialty pharma sector?

Onesource Specialty Pharma
View Company Insights
View All News
like16
dislike

OneSource Specialty Pharma revises 19th AGM time to 5 pm

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • OneSource Specialty Pharma reschedules its 19th AGM to 5:00 pm IST
  • The meeting is held on September 23, 2026, via VC/OAVM
  • It is the company's second annual general meeting after listing
  • Electronic notices and annual reports for FY26 are available online
powered bylight_fuzz_icon
49575383

*this image is generated using AI for illustrative purposes only.

OneSource Specialty Pharma Limited has revised the timing of its 19th Annual General Meeting. The session, scheduled for September 23, 2026, will now commence at 5:00 pm IST instead of the previously announced 11:00 am slot.

The company confirmed the update in a filing dated August 31, 2026. This marks the second AGM for the firm post-listing. The meeting will continue to be conducted through Video Conferencing or Other Audio Visual Means (VC/OAVM).

Revised Meeting Details

Detail Information
Date September 23, 2026
Time 5:00 pm
Mode VC / OAVM
Platform National Securities Depository Limited

Shareholder Participation

Shareholders can join and participate in the AGM only through the VC/OAVM facility. The company will send the notice and annual report for the financial year 2025-26 electronically to members with registered email addresses. These documents are also available on the company website and stock exchange portals.

The company provides a remote e-voting facility for all resolutions. Members who do not vote remotely can exercise their voting rights during the AGM via the e-voting system. Mr. Pradeep Bheemsen Kulkarni of M/s. V Sreedharan & Associates has been appointed as the scrutinizer for the voting process.

Historical Stock Returns for Onesource Specialty Pharma

1 Day5 Days1 Month6 Months1 Year5 Years
-0.85%-1.04%-12.26%+12.79%-18.11%0.0%

What strategic resolutions or executive appointments are expected to be tabled at the upcoming AGM that could signal OneSource's growth trajectory for FY26-27?

How might the shift to a late-afternoon meeting time impact shareholder participation rates and voting turnout compared to previous sessions?

Does the company plan to transition from VC/OAVM to hybrid or in-person meetings in future fiscal years to enhance stakeholder engagement?

Onesource Specialty Pharma
View Company Insights
View All News
like15
dislike

More News on Onesource Specialty Pharma

1 Year Returns:-18.11%